WO2001025264A3 - Substituted phosphinate based peptide derivatives - Google Patents
Substituted phosphinate based peptide derivatives Download PDFInfo
- Publication number
- WO2001025264A3 WO2001025264A3 PCT/EP2000/009173 EP0009173W WO0125264A3 WO 2001025264 A3 WO2001025264 A3 WO 2001025264A3 EP 0009173 W EP0009173 W EP 0009173W WO 0125264 A3 WO0125264 A3 WO 0125264A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- peptide derivatives
- based peptide
- phosphinate based
- substituted phosphinate
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU77785/00A AU7778500A (en) | 1999-09-23 | 2000-09-19 | Substituted phosphinate based peptide derivatives |
EP00967712A EP1220871A2 (en) | 1999-09-23 | 2000-09-19 | Substituted phosphinate based peptide derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9922577.3A GB9922577D0 (en) | 1999-09-23 | 1999-09-23 | Substituted phosphinate based peptide derivatives |
GB9922577.3 | 1999-09-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001025264A2 WO2001025264A2 (en) | 2001-04-12 |
WO2001025264A3 true WO2001025264A3 (en) | 2001-10-18 |
WO2001025264A9 WO2001025264A9 (en) | 2002-09-19 |
Family
ID=10861504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/009173 WO2001025264A2 (en) | 1999-09-23 | 2000-09-19 | Substituted phosphinate based peptide derivatives |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1220871A2 (en) |
AU (1) | AU7778500A (en) |
GB (1) | GB9922577D0 (en) |
WO (1) | WO2001025264A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2996003B1 (en) | 2012-09-25 | 2014-10-17 | Commissariat Energie Atomique | METHOD FOR SPECIFICALLY DETECTION IN SAMPLE MATRIX METALLOPROTEASE (MMP) OF INTEREST ONLY IN ACTIVE FORM |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0276436A1 (en) * | 1986-12-15 | 1988-08-03 | F. Hoffmann-La Roche Ag | Phosphinic acid derivatives |
WO1999003878A2 (en) * | 1997-07-17 | 1999-01-28 | Polifarma S.P.A. | Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
WO2000043404A1 (en) * | 1999-01-19 | 2000-07-27 | Commissariat A L'energie Atomique | Phosphinic pseudopeptides inhibitors of matrix metalloproteases |
-
1999
- 1999-09-23 GB GBGB9922577.3A patent/GB9922577D0/en not_active Ceased
-
2000
- 2000-09-19 AU AU77785/00A patent/AU7778500A/en not_active Abandoned
- 2000-09-19 WO PCT/EP2000/009173 patent/WO2001025264A2/en not_active Application Discontinuation
- 2000-09-19 EP EP00967712A patent/EP1220871A2/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0276436A1 (en) * | 1986-12-15 | 1988-08-03 | F. Hoffmann-La Roche Ag | Phosphinic acid derivatives |
WO1999003878A2 (en) * | 1997-07-17 | 1999-01-28 | Polifarma S.P.A. | Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
WO2000043404A1 (en) * | 1999-01-19 | 2000-07-27 | Commissariat A L'energie Atomique | Phosphinic pseudopeptides inhibitors of matrix metalloproteases |
Non-Patent Citations (8)
Title |
---|
BLAVIER L ET AL: "Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones.", JOURNAL OF CELL SCIENCE, (1995 DEC) 108 ( PT 12) 3649-59., XP002165431 * |
BUCHARDT E.A.: "Phosphinic peptide matrix metalloproteinase-9 inhibitors by solid-phase synthesis using a building block approach", CHEM.EUR.J, vol. 5, no. 10, 24 September 1999 (1999-09-24), pages 2877 - 2884, XP002165432 * |
BUCHARDT E.A.: "Solid phase combinatorial library of phosphinic peptides for discovery of matrix metalloproteinase inhibitors", J.COMB.CHEM, vol. 2, 13 September 2000 (2000-09-13), pages 624 - 638, XP002165433 * |
NAGASE H ET AL: "DESIGN AND CHARACTERIZATION OF A FLUOROGENIC SUBSTRATE SELECTIVELY HYDROLYZED BY STROMELYSIN 1 (MATRIX METALLOPROTEINASE-3)", JOURNAL OF BIOLOGICAL CHEMISTRY,US,AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, vol. 269, no. 33, 19 August 1994 (1994-08-19), pages 20952 - 20957, XP000566937, ISSN: 0021-9258 * |
SATO T ET AL: "The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors.", JOURNAL OF BONE AND MINERAL RESEARCH, (1998 JAN) 13 (1) 59-66., XP000992863 * |
VASSILIOU S ET AL: "Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.", JOURNAL OF MEDICINAL CHEMISTRY, (1999 JUL 15) 42 (14) 2610-20., XP002165434 * |
YIALLOUROS I ET AL: "Phosphinic peptides, the first potent inhibitors of astacin, behave as extremely slow-binding inhibitors.", BIOCHEMICAL JOURNAL, (1998 APR 15) 331 ( PT 2) 375-9., XP002165429 * |
YIOTAKIS, ATHANASIOS ET AL: "Protection of the Hydroxyphosphinyl Function of Phosphinic Dipeptides by Adamantyl. Application to the Solid-Phase Synthesis of Phosphinic Peptides", J. ORG. CHEM. (1996), 61(19), 6601-6605, XP002165430 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001025264A9 (en) | 2002-09-19 |
EP1220871A2 (en) | 2002-07-10 |
WO2001025264A2 (en) | 2001-04-12 |
GB9922577D0 (en) | 1999-11-24 |
AU7778500A (en) | 2001-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1048990A1 (en) | Novel compounds. | |
PL366198A1 (en) | Novel compounds | |
GB9813540D0 (en) | Chemical compounds | |
BG105270A (en) | Tetrahydropyridoethers | |
AU2001272849A1 (en) | Composition for the treatment of osteoarthritis | |
PL367682A1 (en) | Dolastatin 10 derivatives | |
CY2538B1 (en) | Tetrahydropyrido compounds | |
BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
AU3850600A (en) | Dalda analogs and their use | |
WO2000021910A3 (en) | 1,2-disubstituted cyclopropanes | |
AU1044500A (en) | Imidazonaphthyridines | |
SE0203070D0 (en) | Novel compounds | |
BG106155A (en) | Novel derivatives and analogues of galanthamin | |
IL132599A0 (en) | Substituted 3,3-diamino-2-propenenitriles their preparation and use | |
AU4080097A (en) | Piperazino derivatives as neurokinin antagonists | |
HK1068348A1 (en) | Therapeutic heterocycles as bradykinin b2 receptorantagonists | |
AU7027100A (en) | Novel compounds | |
TR200200278T2 (en) | Calcilitic compositions | |
AU3896899A (en) | Compositions for the treatment of tumors, and uses thereof | |
WO2001025264A3 (en) | Substituted phosphinate based peptide derivatives | |
AU2003255843A1 (en) | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain | |
YU19302A (en) | 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use | |
EP1436279B8 (en) | Chemical compounds | |
MY133140A (en) | N-substituted azabicycloheptane derivatives, their preparation and use | |
PL355113A1 (en) | Novel fusidic acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 77785/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000967712 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000967712 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 105-117, CLAIMS, REPLACED BY NEW PAGES 105-118; AFTER RECTIFICATION OF OBVIOUS ERRORS AS AUTHORIZED BY THE INTERNATIONAL SEARCHING AUTHORITY; PAGE 2/31, DRAWINGS, REPLACED BY A NEW PAGE 2/31 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000967712 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |